+49 1512 3540861

Services

High-Throughput IHC and Multiplex Services for Biomarker Discovery

Scalable staining, imaging, and analysis using our domain-specific antibodies on FFPE tissue—designed for translational research and target validation across large tumor cohorts.

Overview

We provide single-marker IHC and multiplex immunohistochemistry services using one or more of our recombinant antibodies. These services enable researchers to investigate domain-specific target expression, co-expression patterns, and spatial heterogeneity across diverse tumor types.

Whether you are:

Validating a therapeutic target

Profiling biomarkers across cancer subtypes

Exploring mutual exclusivity in tumor microenvironments

—our platform delivers efficient, high-quality staining and analysis at scale.

What’s Included

Staining with single antibodies or multiplex panels

Using our IHC-validated, domain-specific antibodies (e.g., HER2, HER3, EGFR, TROP2, and others)

Inclusion of non-catalog antibodies possible (upon review)

FFPE sample handling

FFPE tissue microarrays (TMAs)

Customer-supplied blocks or pre-cut slides

Commercially sourced tumor samples

High-resolution imaging

Brightfield or multispectral imaging with calibrated systems

Quantitative analysis & reporting

Image segmentation, scoring, and data export (custom formats available)

Common Use Cases

Biomarker profiling across tumor entities

Preclinical validation of therapeutic targets

Multiplexed detection of co-expressed or mutually exclusive domains

Domain-specific expression screening for ADC and CAR-T development

Pricing

From 19 € per tumor sample and marker

Minimum order: 100 samples

Final pricing depends on tumor type, staining complexity, and panel size

Tell us about your project

We’ll provide a tailored quote or arrange a short call to discuss the best approach.

Turnaround times and reporting formats can be adapted to your workflow.

Contact us